To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes

Francesco Lapi; Ettore Marconi; Gerardo Medea; Damiano Parretti; Carlo Piccinni; Aldo Maggioni; Claudio Cricelli

doi:10.1007/s12020-023-03419-2

Related publications

Article2025

Heart failure diagnosis: Impacts of atrial fibrillation on the diagnostic marker NT-proBNP

Yang Chen, Garry McDowell, Professor Gregory Lip

Article2024

Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials

Toru Kondo, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo Maggioni, Felipe A Martinez, M REDFIELD, Jean‐Lucien Rouleau, D.J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Scott D. Solomon, John J.V. McMurray

Article2018

The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure

Arkadiusz Retwiński, Marcin Kosmalski, María G. Crespo‐Leiro, Aldo Maggioni, Grzegorz Opolski, Piotr Ponikowski, Lech Poloński, Ewa A. Jankowska, Jerzy Drzewoski, Jarosław Dróżdż

Article2023

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek‐Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Professor Gregory Lip

Letter2017

Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Køber, Francesca Lawson, Eldrin F. Lewis, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean‐Claude Tardif, Marc A. Pfeffer